XENiOS® Will Seek Regulatory Approval for i-lung®

XENiOS®, a commercial-stage medical device company, announced today it expects to receive CE-marking for its i-lung® device within 18 months. XENIOS expects to launch i-lung® in 2017. Currently available devices lack durability and wearability. Additionally, the size of current systems restricts patient mobility and limits quality of life. i-lung represents an innovative and first-of-its-kind fully wearable artificial lung for long-term use in a hospital environment.

"The availability of i-lung will open the door to significant medical progress for respiratory support. For many patients in lung failure currently undergoing invasive mechanical ventilation, the use of i-lung is designed to avoid sedation and immobility, thus creating active, self-managed patients," said Georg Matheis, MD, Managing Director & Founder of XENIOS. "In addition, i-lung is designed to be used to bridge the waiting time for a donor organ (bridge-to-lung-transplant)."

"Of special note," added Juergen Boehm, MD, Managing Director of Xenios, "i-lung paves the way for XENiOS to continue development of a bioartificial lung for use by patients outside of a hospital environment analogous to current artificial heart protocols, which will represent a paradigm shift in the approach to long-term respiratory support."

i-lung is the result of the successful completion of the AmbuLung project, a three-year R&D consortium project funded by the European Union’s FP7 Program that developed the basis for i-lung, the world’s first-of-its-kind wearable artificial lung. In addition to XENiOS, the consortium included Fraunhofer IGB (Stuttgart, Germany); Imperial College of Science, Technology and Medicine (London, UK); and, the University of Florence (Italy).

"We are forever indebted to the vision and the work of Professor Dame Julia Polak, who passed away last year," said Dr. Matheis. "Julia and I co-founded the i-lung project, and because of her enormous contribution i-lung is now a reality, and a bioartificial next-gen of i-lung on the horizon." The author of some 1,000 original papers, 115 review articles and editor or author of 25 books, Julia Polak, MD, PhD, was one of the most widely cited researchers in her field, and had undergone a heart lung transplant. She served on several national and international tissue engineering and stem cell advisory panels, and was the European editor of the journal Tissue Engineering.

Funding for the commercialization of i-LUNG® has already been procured. XENIOS announced in September 2015 that it received an eight-figures cash infusion from existing investors, in part to fund CE-marking and launch of i-LUNG, led by ZFHN, one of the largest Single Family Offices in Germany investing in start-up companies.

About XENiOS®
XENiOS AG is a privately held medical technology company that is comprised of two product brands, novalung® and i–cor®, that run on a single XENiOS® console. The XENIOS platform is designed to provide at least four essential advantages with its minimally invasive lung and heart therapies: (1) patients are awake and mobile;(2) self-actuated patients facilitate improved outcomes; (3) there is no ventilator-associated lung injury or pneumonia; (4) additionally, the XENIOS platform maintains a physiologic natural pulse designed to protect the heart.

Most Popular Now

Kick-off Meeting for eHealth Hub: An Int…

The Kick-off Meeting of the eHealth Hub project took place on the 20th and 21st of October 2016, in Murcia (Spain). The meeting effectively launched the activities of a newly...

Read more

HIV Test Performed on USB Stick

Scientists have developed a type of HIV test on a USB stick. The device, created by scientists at Imperial College London and DNA Electronics, uses a drop of blood to...

Read more

Major Health IT Event Opens with Recogni…

21 - 22 November 2016, Barcelona, Spain. The World of Health IT (WoHIT) has opened its doors to over 1,000 healthcare IT professionals from across 25 different countries worldwide. Covering a...

Read more

Emergency Video Telemedicine Positively …

Approximately 10 percent of newborns require help breathing after birth, and 1 in 1,000 newborns require more intensive resuscitation measures. These infrequent, high-risk deliveries may present challenges to community hospitals...

Read more

Crack the Human Brain

The time is ripe, the communication technology is available, for teams from different labs and different countries to join efforts and apply new forms of grassroots collaborative research in brain...

Read more

EC Open Call SC1-PM-15-2017: Personalise…

The activity aims at developing and validating radically new ICT based concepts and approaches for empowering and motivating people in need of guidance and care due to age related conditions...

Read more

MEDICA and COMPAMED 2016 Provide a Power…

14 - 17 November 2016, Düsseldorf, Germany. Once again, the world's biggest medical trade fair MEDICA and the leading international supplier trade fair COMPAMED, which take place in Düsseldorf, have provided...

Read more

Open Call SC1-HCO-08-2017: Actions to Br…

Despite serious efforts deployed at national and European level, the European Union sees significant internal disparities in terms of research and innovation performance as also identified in the Innovation Union...

Read more

Chronically Ill Women Underusing Online …

Barriers to internet use may be preventing chronically ill middle-aged and older women from being as healthy as they otherwise could be, new research suggests. The study conducted by researchers...

Read more

MEDICA 2016 + COMPAMED 2016 with over 5…

14 - 17 November 2016, Düsseldorf, Germany. When top decision-makers in the healthcare business meet in Düsseldorf again in the middle of November at the world's leading medical trade fair, MEDICA...

Read more

The International Health Industry Comes …

14 - 17 November 2016, Düsseldorf, Germany. Decision makers from all sectors of the international health industry meet again in Düsseldorf from Monday to Thursday. The world's biggest medical trade fair...

Read more

Health at a Glance: Europe 2016

This publication is the result of a close co-operation between the OECD and the European Commission and is the first step in the Commission's "State of Health in the EU...

Read more
(HEALTH IT) SPACE - Take a look at who has just Joined